You are here: Industry Insights > Eton

News List

Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO Hydrocortisone Autoinjector firstwordpharma
June 16, 2021
Eton Pharmaceuticals, Inc (Nasdaq: ETON), today announced that it has acquired U.S. and Canadian rights to Crossject's ZENEO® hydrocortisone needleless autoinjector, which is under development as a rescue treatment for adrenal crisis.
FDA Approves Bausch + Lomb Alaway Preservative Free Ophthalmic Solution americanpharmaceuticalreview
October 09, 2020
Bausch Health, Bausch + Lomb, and Eton Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Alaway® Preservative Free (ketotifen fumarate) ophthalmic solution, 0.035%, antihistamine eye drops (EM-100) ...
Eton Announces Commercial Availability of Biorphen Injection americanpharmaceuticalreview
December 30, 2019
Eton Pharmaceuticals announced Biorphen®, the first and only FDA-approved ready-to-use formulation of phenylephrine for the treatment of clinically important hypotension ...
Eton Receives NDA Acceptance for Oral Liquid Seizure Medication contractpharma
August 30, 2019
ET-105 addresses unmet needs of patients with dysphagia and pediatric patients requiring doses lower than available tablet strengths.
Eton Provides Update on EM-100 Program americanpharmaceuticalreview
July 18, 2019
Eton Pharmaceuticals announced the U.S Food and Drug Administration (FDA) provided Eton’s partner with a Complete Response Letter (CRL) relating to the application for EM-100 ......